Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Net Margin (2016 - 2021)

Historic Net Margin for Neurocrine Biosciences (NBIX) over the last 11 years, with Q3 2021 value amounting to 7.6%.

  • Neurocrine Biosciences' Net Margin rose 298800.0% to 7.6% in Q3 2021 from the same period last year, while for Dec 2021 it was 11.8%, marking a year-over-year increase of 61200.0%. This contributed to the annual value of 4.7% for FY2019, which is 200.0% up from last year.
  • Neurocrine Biosciences' Net Margin amounted to 7.6% in Q3 2021, which was up 298800.0% from 14.64% recorded in Q2 2021.
  • Neurocrine Biosciences' Net Margin's 5-year high stood at 33.45% during Q3 2018, with a 5-year trough of 960.76% in Q2 2017.
  • Over the past 5 years, Neurocrine Biosciences' median Net Margin value was 13.57% (recorded in 2021), while the average stood at 55.35%.
  • Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 9546600bps in 2018, then plummeted by -465100bps in 2020.
  • Over the past 5 years, Neurocrine Biosciences' Net Margin (Quarter) stood at 7.29% in 2017, then skyrocketed by 96bps to 14.3% in 2018, then dropped by -3bps to 13.93% in 2019, then tumbled by -260bps to 22.28% in 2020, then surged by 134bps to 7.6% in 2021.
  • Its Net Margin stands at 7.6% for Q3 2021, versus 14.64% for Q2 2021 and 13.57% for Q1 2021.